The detection of DNA of the helper virus-dependent adeno-associated virus type 2 (AAV-2) in biopsies of material from spontaneous abortion and in tissue samples from the uterus raises the question of whether sequences of known helper viruses can be detected simultaneously within the same specimen despite the lack of histological evidence for the presence of lytic viruses. Therefore, we performed PCR analyses with primers detecting DNA sequences of viruses (adenovirus, herpes simplex virus and human cytomegalovirus) known for their helper activity in the replication of adeno-associated viruses. In addition, PCR was performed to detect DNA of human papillomaviruses (HPV), which were recently shown to be able to help AAV replication in vitro. In no cases were sequences of the known helper viruses found. However, HPV DNA was detected in $ 60 % of paraffin sections from uterus biopsies and cervical lesions containing AAV DNA and in $ 70 % of material from early miscarriage. This finding suggests that HPV may be a helper virus for AAV.
was confirmed and AAV-2 DNA sequences were found to be present in clinical samples from human genital tissues (Friedman-Einat et al., 1997 ; Han et al., 1996) . In order to assess the presence of co-infecting helper viruses in histological (paraffin embedded) sections of biopsies, we performed PCR analyses to detect the presence of DNA sequences of viruses known to help AAV replication, i.e. adenovirus (Ad), herpes simplex virus (HSV-1 and HSV-2) and human cytomegalovirus (HCMV) (Buller et al., 1981 ; Georg-Fries et al., 1984 ; McPherson et al., 1985 ; Myers et al., 1980) . In addition, the presence of human papillomavirus (HPV) DNA sequences was investigated since this virus has recently been demonstrated to be a potential helper virus for AAV (Walz et al., 1997) . Table 1 presents the primers and PCR conditions used in this study. Briefly, deparaffinization, DNA extraction from the sections and PCR analysis for the presence of AAV-2 DNA were carried out as described by Tobiasch et al. (1994) .
For detection of HCMV, HSV, HPV or Ad sequences, 80 pM\ml, or 100 pM\ml for HPV, of each primer was mixed with buffer (10 mM Tris, 50 mM KCl, 20 µg\ml acetylated BSA) and 120 µM of each dNTP plus 5 units of Taq polymerase. Concentrations of MgCl # used were 1n5 mM for HCMV, HSV, HPV type-specific primers or Ad and 5 mM, 2n5 mM or 2 mM for HPV general primers respectively. PCR cycles were as described in the references in Table 1 . Typespecific PCR of HPV was performed with single pairs of primers and not as multiplex.
As positive control samples, DNA of HCMV-, HSV-1-or HSV-2-infected MRC5 cells, HCMV-positive urine samples, DNA of Ad type 2-infected HeLa cells, DNA from HeLa and SiHa cells (containing HPV-18 and HPV-16 DNA respectively) and DNA from a condyloma acuminatum biopsy (containing HPV-11 DNA) were used.
For detection of AAV, the positive control was obtained after treatment, as above, of paraffin-embedded sections from In the given sequences, S represents (G. C), W represents (A, T), and Y represents (C, T). * Nucleotide sequence within the respective amplified fragment used for confirmation of specificity by radiolabelled hybridization. † Positions of primers in the published sequence of HCMV. ‡ Positions of primers in the published sequences of HSV-1 and HSV-2. § Positions of the primers in the published sequence of Ad-2. According to EMBL and GenBank databanks, these primers recognize sequences common to Ad types 2, 5 and 7. Respective positions in Ad-5 are 3955 and 4815. ¶ GP1/GP2, GP5/GP6 and CP-I/CP-IIg are generic primers for any HPV type. Human genital tissue contains AAV and HPV DNA Human genital tissue contains AAV and HPV DNA * 51 samples were examined for Ad, all of which were tested for HCMV, HSV-1 and HPV and 37 of which were tested for HSV-1/2. † 53 samples were examined for HCMV, of which 51 were tested for Ad, 52 for HSV-1, 37 for HSV-1/2 and 52 for HPV. ‡ 52 samples were examined for HSV-1, of which 52 were tested for HCMV, 51 for Ad, 37 for HSV-1/2 (shown in brackets; see also following footnote) and 52 for HPV. § 37 samples were examined for HSV-1/2, all of which were tested for HCMV, HSV-1 and HPV and 36 of which were tested for Ad. ¶ 52 samples were examined for HPV, of which 52 were tested for HCMV, 51 for Ad, 52 for HSV-1 and 37 for HSV-1/2. tumours in nude mice after injection of HA16 cells containing AAV-2 DNA (Walz & Schlehofer, 1992) . PCR-amplified products were separated by agarose gel electrophoresis and, in most cases, confirmed for specificity by Southern blot analysis using radiolabelled DNA oligonucleotide probes (5h-end-labelled with [γ-$#P]dATP) hybridizing within the amplified sequences after Southern blotting (Table 1) .
We analysed (Table 2) by PCR 13 histological (paraffin) sections of the cervix uteri, nine endometrium biopsies, 26 samples of abortion material, two samples of curettage material of extrauterine gravidity and one sample of socially indicated abortion, which were previously confirmed as positive for AAV-2 DNA. Fifty-three samples were tested for HCMV, 51 for Ad, 52 for HSV-1 and 37 for HSV-2. Fifty-one samples were tested for all of these viruses in parallel ( Table 2) . None of the specimens containing AAV-2 DNA contained sequences of the known helper viruses mentioned above. One sample from early abortion and one cervical biopsy which did not contain AAV-2 DNA, used as controls, were also negative for helper virus DNA sequences.
However, in material from the uterus, sequences of HPV DNA were detected using general primers in 13 out of 21 AAV DNA-containing samples. In material from early abortion, HPV DNA sequences were found in 18 out of 26 specimens positive for AAV DNA ( Table 2 ). The number of HPV-positive samples may be underestimated since it is known that general primers sometimes fail to detect HPV sequences in paraffin sections (Baay et al., 1996) .
When possible, depending on the amount of material, the presence of genital HPV types was confirmed for HPVpositive samples using type-specific anti-contamination primers (van den Brule et al., 1989) . DNAs of HPV-16, -18 and -11 were identified ; sometimes more than one type was found within the same sample [two uterus mucosa, two cervical intraepithelial neoplasia (CIN) and one early miscarriage samples were positive for both HPV-16 and HPV-18 DNA, one early miscarriage sample was positive for HPV-16, HPV-18 and HPV-11 DNA, one extrauterine gravidity sample was positive for both HPV-16 and HPV-11, and one cervix uteri sample was positive for both HPV-18 and HPV-11]. None of the samples contained HPV-6 or HPV-31\-33 DNA.
Some samples which were positive for the presence of HPV DNA could not be identified as containing one of the HPV types tested in our experiments. On the other hand, eight samples which were found to be negative when using generic HPV primer pairs were later typed as HPV-16, HPV-18 or HPV-11, confirming the lower sensitivity of general primers compared to type-specific ones (Walboomers et al., 1992) .
In order to extend the above results, which were obtained with paraffin-embedded cervical tissues, 17 additional, freshly excised, cervix uteri samples (CIN lesions) were examined using PCR for AAV, HPV-16 and HPV-18 DNAs (Fig. 1) . Out of 13 AAV-positive samples, seven were also HPV-16-positive 1 . Analysis by PCR for the presence of AAV-2, HPV-16 and HPV-18 DNA sequences in fresh cervical biopsies (CIN lesions). (a) Southern blot of PCR-amplified AAV-2 sequences probed with a γ-32 P-labelled oligonucleotide as described in Tobiasch et al. (1994) . Controls are HA16 cells containing both HPV-18 and AAV-2 DNA (Walz & Schlehofer, 1992) and SiHa cells containing HPV-16 DNA. Cervix uteri biopsy samples are numbered 1 to 18 (number 7 is absent). (b) Southern blot of PCR-amplified HPV-16 sequences probed with a γ-32 P-labelled oligonucleotide as described in Walboomers et al. (1992) . Controls are those used in (a), plus an additional control containing mixed DNAs from HA16 and SiHa, added to exclude the possibility of cross-hybridization. Cervix uteri samples are numbered 1 to 18 (number 7 is absent and 8 and 9 are inverted). (c) Southern blot of PCR-amplified HPV-18 sequences probed with a γ-32 P-labelled oligonucleotide as described in Walboomers et al. (1992) . Controls and sample numbers are as in (b).
and none were HPV-18-positive. Small differences in band sizes or hybridization signals suggested amplification of sequences of different AAV types [the pan1 and pan3 primers detect sequences of AAV-2, -3 and -5 (Tobiasch et al., 1994) ].
To exclude this possibility, amplification products were sequenced and identified as AAV-2 DNA (data not shown) and so were not due to amplification of AAV-3 (Muramatsu et al., 1996) or AAV-5 (E. Tobiasch, personal communication) sequences.
In view of the frequent detection of HPV in human genital tissue (Burk et al., 1986 ; von Knebel Doeberitz, 1992) and in view of our recent in vitro results (Walz et al., 1997) , it is possible that HPV may provide at least some helper function for AAV replication, adding another virus to the list of potential helpers for this parvovirus. The detection of the oncosuppressive parvovirus AAV in the cervix uteri, the same tissue that is transformed by oncogenic papillomaviruses (von Knebel Doeberitz, 1992 ; zur Hausen, 1991) , seems to be of particular interest. Epidemiological studies have demonstrated an inverse correlation between the prevalence of serum Human genital tissue contains AAV and HPV DNA Human genital tissue contains AAV and HPV DNA antibodies to AAV and cervical carcinoma (see review by Schlehofer, 1994) . It is tempting to speculate on the influence of AAV on the tumorigenic activity of HPV. This is supported by the finding of down-regulation of HPV gene expression by AAV (Hermonat, 1994 ; Ho$ rer et al., 1995) . AAV has been demonstrated to induce differentiation in various cell systems (Klein-Bauernschmitt et al., 1992) and this may in addition contribute to an interference with HPV functions in view of the involvement of differentiation processes in the maturation of papillomaviruses (Du$ rst et al., 1992 ; Stoler et al., 1989 ; cf. also Rabreau & Schlehofer, 1995) . We reported previously the detection of large amounts of AAV-2 DNA and of AAV gene expression in the syncytiotrophoblast of abortion material (Tobiasch et al., 1994) . Possibly, persistent AAV becomes reactivated during pregnancy and can infect specific cells. Whether papillomaviruses, which are known to be reactivated during pregnancy (Monsonego et al., 1991 ; Patsner et al., 1990 ; Robertson et al., 1993 ; Schneider et al., 1987) , help in this process remains to be determined.
HPV DNA detected in abortion material could indicate infection of embryonic tissues with these viruses. However, contamination of the curettage material by cells of the cervix uteri (in which HPV DNA is frequently present) cannot be excluded. DNA of papillomaviruses has also recently been reported in amniotic fluids (Armbruster-Moraes et al., 1993 .
Recent results (Friedman-Einat et al., 1997) confirm our finding of AAV DNA sequences in the genital tract, although discrepancies in the number of samples positive for AAV DNA and DNA of possible helper viruses obtained by Han et al. (1996) and Friedman-Einat et al. (1997) remain to be elucidated. Our data suggest that papillomaviruses could provide helper functions for AAV-2 within human genital tissues. However, it cannot be excluded that functions of known AAV helper viruses (Ad, HCMV and HSV) have contributed to the establishment of AAV infection within the genital area.
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